Skip to content
drillr.ai

ADMA

ADMA Biologics, Inc.

NASDAQ · USHealthcareBiotechnology
$8.75+0.46%

Price as of Jul 20, 2026

ADMA news

ADMA Biologics, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. Did You Lose Money on ADMA Biologics, Inc. (ADMA)? Levi & Korsinsky Urges Investors to Act Before August 10, 2026

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities. If you suffered a loss on your ADMA Biologics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about ADMA Biologics, Inc. Class Action (https://pr.report/ny0w) or

    ACCESSWIRE ·

  2. ADMA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 20, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ:ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased ADMA Biologics securities during the Class Period you may b

    ACCESSWIRE ·

  3. Lost Money on ADMA Biologics, Inc. (ADMA)? Join Class Action Before August 10, 2026 - Contact Levi & Korsinsky

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities. If you suffered a loss on your ADMA Biologics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about ADMA Biologics, Inc. Class Action (https://pr.report/nxfh) or

    ACCESSWIRE ·

  4. $ADMA Stock Drop: ADMA Biologics Investors Notified of the Securities Fraud Class Action to Recover Losses Over Channel Stuffing Allegations

    A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws. NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 20, 2026 / Leading securities law firm Bleichmar Fonti & Auld LLP (https://pr.report/nvju) announces that a class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ:ADMA) and certain of th

    ACCESSWIRE ·

  5. ADMA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA

    New York, New York--(Newsfile Corp. - July 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased ADMA Biologics securities during the Class Period you may be entitled to compensation witho

    Newsfile Corp ·

  6. ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

    LOS ANGELES, July 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm (https://www.globenewswire.com/Tracker?data=z6g7haTk9hliZnBkSOJVMK1eKwR8IQJFrtOnLGCfCKPLCd1fOa8M1nS9-aZ0zkmj-1kgCoxpR02lZYipHkv8FReNA5iqhtM4ACP9t_Zm4Mg=), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ADMA Biologics, Inc. (“ADMA” or “the Company”) (NASDAQ: ADMA (https://www.globenewswire.com/Tracker?data=uivcCqcf96Vbj987sSk1nZlrAa7qkDS4crpza8Oy1KLSSliZ8N0tAv64yTZaNdbVpw5A3TfnPF

    Globe Newswire ·

  7. DEADLINE ALERT for BTGO, VIA, Z, ADMA: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

    BENSALEM, Pa., July 20, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at (215) 638-4847 or by email to howardsmith@

    Globe Newswire ·

  8. August 10, 2026 Deadline Approaching: Join Class Action Against ADMA Biologics, Inc. (ADMA) - Contact Levi & Korsinsky

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities. If you suffered a loss on your ADMA Biologics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about ADMA Biologics, Inc. Class Action (https://pr.report/nxbt) or

    ACCESSWIRE ·

  9. Levi & Korsinsky Urges ADMA Biologics, Inc. (ADMA) Shareholders to Act Before Lead Plaintiff Deadline August 10, 2026

    NEW YORK, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 20, 2026 / NEW YORK, NY / ACCESS Newswire / July 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities. If you suffered a loss on your ADMA Biologics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about ADMA Biologics, In

    ACCESSWIRE ·

  10. $ADMA Legal News: ADMA Biologics Accused of Misrepresentations about its Revenue Sources in Securities Fraud Class Action – Investors Notified to Contact BFA Law

    NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP (https://www.globenewswire.com/Tracker?data=JViyecNxWcXXYhQFZLt2DDTl9dFEAKh6kG2CF3QWFBUMObQMLKUyQ1RZGNhljYBlNvwNgoBKO9TP7mz7QrKA9Rg_RZ33yHwdIEW9bV5DD-m1ufBNiZ1y8HfV0Cy_baTWtJDp0VETg0D01qAT4gmhh73R0x1IeMOjMCLjTdRAg48=) announces that a class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ:ADMA) and certain of the Company’s senior executives for securities fraud after its significa

    Globe Newswire ·

  11. Securities Lawsuit Alert: ADMA Biologics, Inc. (ADMA) - Contact Levi & Korsinsky Before August 10, 2026

    NEW YORK, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities. If you suffered a loss on your ADMA Biologics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about ADMA Biologics, Inc. Class Action (https://pr.report/nwyg) or conta

    ACCESSWIRE ·

  12. ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA

    ADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA PR Newswire LOS ANGELES, July 20, 2026 LOS ANGELES, July 20, 2026 /PRNewswire/ -- The DJS Law Group (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4734580-1&h=2909021276&u=https%3A%2F%2Fdjslawllp.com%2F&a=The+DJS+Law+Group)  reminds investors of a class action lawsuit against ADMA Biologics, Inc. ("ADMA" or "the Company") (NASDAQ: ADMA (https://edge.prnewswire.com/c/link/?t=0&l=e

    PR Newswire ·

  13. Shareholders of ADMA Biologics, Inc. (ADMA): Protect Your Rights Before August 10, 2026 – Contact Levi & Korsinsky

    NEW YORK, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 19, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities. If you suffered a loss on your ADMA Biologics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about ADMA Biologics, Inc. Class Action (https://pr.report/nwup) or conta

    ACCESSWIRE ·

  14. ADMA BIOLOGICS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA

    NEW YORK, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 19, 2026 / The Rosen Law Firm, P.A. WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ:ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased ADMA Biologics securities during the C

    ACCESSWIRE ·

  15. Investor Alert: Deadline Approaching to Join ADMA Biologics, Inc. (ADMA) Class Action – Contact Levi & Korsinsky

    NEW YORK, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 19, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities. If you suffered a loss on your ADMA Biologics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about ADMA Biologics, Inc. Class Action (https://pr.report/nwt5) or conta

    ACCESSWIRE ·

  16. Pomerantz LLP Informs Shareholders of Securities Class Action Against ADMA Biologics, Inc. – ADMA

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 19, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ:ADMA).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The c

    ACCESSWIRE ·

  17. Recover Investment Losses: Class Action Initiated Against ADMA Biologics, Inc. (ADMA)

    NEW YORK, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 19, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities. If you suffered a loss on your ADMA Biologics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about ADMA Biologics, Inc. Class Action (https://pr.report/nwqf) or conta

    ACCESSWIRE ·

  18. Pomerantz LLP Issues Important Reminder to Investors in ADMA Biologics, Inc. of Class Action – ADMA

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 19, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ:ADMA).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The c

    ACCESSWIRE ·

  19. August 10, 2026 Deadline Approaching: Join Class Action Against ADMA Biologics, Inc. (ADMA) – Contact Levi & Korsinsky

    NEW YORK, NY / ACCESS Newswire (https://www.accessnewswire.com/) / July 19, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities. If you suffered a loss on your ADMA Biologics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about ADMA Biologics, Inc. Class Action (https://pr.report/nwo2) or conta

    ACCESSWIRE ·

  20. ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

    NEW YORK, July 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the “Class Period”), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased ADMA Biologics securities during the Class Period you may be entitled to compensation without payment

    Globe Newswire ·